Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Unger

Showing results (291-300 of 307) with videos related to

Pageof 31
Sort By:
The Journal of Clinical Psychiatry|September 29, 2011
Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressantThomas P Laughren, Jogarao Gobburu, Robert J Temple, et al.
JACC. Heart Failure|August 12, 2019
Design of a "Lean" Case Report Form for Heart Failure Therapeutic DevelopmentMitchell A Psotka, Mona Fiuzat, Peter E Carson, et al.
Journal of the American College of Cardiology|April 16, 2021
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the WeekJames L Januzzi, John M Canty, Saumya Das, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
European Journal of Heart Failure|October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
BMC Biology|January 4, 2020
Evolutionary superscaffolding and chromosome anchoring to improve Anopheles genome assembliesRobert M Waterhouse, Sergey Aganezov, Yoann Anselmetti, et al.
Genome Biology|September 24, 2014
Genome analysis of a major urban malaria vector mosquito, Anopheles stephensiXiaofang Jiang, Ashley Peery, A Brantley Hall, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Pageof 31

Showing results (291-300 of 307) with videos related to

Sort By:
Pageof 31
The Journal of Clinical Psychiatry|September 29, 2011
Vilazodone: clinical basis for the US Food and Drug Administration's approval of a new antidepressantThomas P Laughren, Jogarao Gobburu, Robert J Temple, et al.
JACC. Heart Failure|August 12, 2019
Design of a "Lean" Case Report Form for Heart Failure Therapeutic DevelopmentMitchell A Psotka, Mona Fiuzat, Peter E Carson, et al.
Journal of the American College of Cardiology|April 16, 2021
Gaining Efficiency in Clinical Trials With Cardiac Biomarkers: JACC Review Topic of the WeekJames L Januzzi, John M Canty, Saumya Das, et al.
Clinical Pharmacology and Therapeutics|February 17, 2012
Adaptive licensing: taking the next step in the evolution of drug approvalH-G Eichler, K Oye, L G Baird, et al.
JACC. Heart Failure|November 17, 2020
Standardized Definitions for Evaluation of Heart Failure Therapies: Scientific Expert Panel From the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
European Journal of Heart Failure|October 5, 2020
Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the Heart Failure Collaboratory and Academic Research ConsortiumWilliam T Abraham, Mitchell A Psotka, Mona Fiuzat, et al.
JACC. Heart Failure|December 1, 2022
Functional and Symptomatic Clinical Trial Endpoints: The HFC-ARC Scientific Expert PanelMitchell A Psotka, William T Abraham, Mona Fiuzat, et al.
BMC Biology|January 4, 2020
Evolutionary superscaffolding and chromosome anchoring to improve Anopheles genome assembliesRobert M Waterhouse, Sergey Aganezov, Yoann Anselmetti, et al.
Genome Biology|September 24, 2014
Genome analysis of a major urban malaria vector mosquito, Anopheles stephensiXiaofang Jiang, Ashley Peery, A Brantley Hall, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
From adaptive licensing to adaptive pathways: delivering a flexible life-span approach to bring new drugs to patientsH-G Eichler, L G Baird, R Barker, et al.
Pageof 31